603 related articles for article (PubMed ID: 29105055)
1. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.
Demarest ST; Shellhaas RA; Gaillard WD; Keator C; Nickels KC; Hussain SA; Loddenkemper T; Patel AD; Saneto RP; Wirrell E; Sánchez Fernández I; Chu CJ; Grinspan Z; Wusthoff CJ; Joshi S; Mohamed IS; Stafstrom CE; Stack CV; Yozawitz E; Bluvstein JS; Singh RK; Knupp KG;
Epilepsia; 2017 Dec; 58(12):2098-2103. PubMed ID: 29105055
[TBL] [Abstract][Full Text] [Related]
2. Response to treatment in a prospective national infantile spasms cohort.
Knupp KG; Coryell J; Nickels KC; Ryan N; Leister E; Loddenkemper T; Grinspan Z; Hartman AL; Kossoff EH; Gaillard WD; Mytinger JR; Joshi S; Shellhaas RA; Sullivan J; Dlugos D; Hamikawa L; Berg AT; Millichap J; Nordli DR; Wirrell E;
Ann Neurol; 2016 Mar; 79(3):475-84. PubMed ID: 26704170
[TBL] [Abstract][Full Text] [Related]
3. Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms.
Yuskaitis CJ; Mytinger JR; Baumer FM; Zhang B; Liu S; Samanta D; Hussain SA; Yozawitz EG; Keator CG; Joshi C; Singh RK; Bhatia S; Bhalla S; Shellhaas R; Harini C;
Neurology; 2022 Nov; 99(22):e2494-e2503. PubMed ID: 36038267
[TBL] [Abstract][Full Text] [Related]
4. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
[TBL] [Abstract][Full Text] [Related]
5. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.
Knupp KG; Leister E; Coryell J; Nickels KC; Ryan N; Juarez-Colunga E; Gaillard WD; Mytinger JR; Berg AT; Millichap J; Nordli DR; Joshi S; Shellhaas RA; Loddenkemper T; Dlugos D; Wirrell E; Sullivan J; Hartman AL; Kossoff EH; Grinspan ZM; Hamikawa L;
Epilepsia; 2016 Nov; 57(11):1834-1842. PubMed ID: 27615012
[TBL] [Abstract][Full Text] [Related]
6. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
[TBL] [Abstract][Full Text] [Related]
7. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
[TBL] [Abstract][Full Text] [Related]
8. Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapies.
Olson HE; Demarest S; Pestana-Knight E; Moosa AN; Zhang X; Pérez-Pérez JR; Weisenberg J; O'Connor Prange E; Marsh ED; Rajaraman RR; Suter B; Katyayan A; Haviland I; Daniels C; Zhang B; Greene C; DeLeo M; Swanson L; Love-Nichols J; Benke T; Harini C; Poduri A
Epilepsia; 2023 Jul; 64(7):1821-1832. PubMed ID: 37114835
[TBL] [Abstract][Full Text] [Related]
9. Vigabatrin for infantile spasms.
Pesaturo KA; Spooner LM; Belliveau P
Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
[TBL] [Abstract][Full Text] [Related]
10. Neurodevelopmental and epilepsy outcomes of patients with infantile spasms treated in a tertiary care center.
Bashiri FA; Al-Sehemi MA; Hamad MH; Alshammari NR; Aljumah MA; Kentab A; Salih MA
Neurosciences (Riyadh); 2021 Jan; 26(1):21-25. PubMed ID: 33530039
[TBL] [Abstract][Full Text] [Related]
11. Treatment of infantile spasms.
Hancock EC; Osborne JP; Edwards SW
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001770. PubMed ID: 23740534
[TBL] [Abstract][Full Text] [Related]
12. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
[TBL] [Abstract][Full Text] [Related]
14. Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
Jones K; Snead OC; Boyd J; Go C
J Child Neurol; 2015 Apr; 30(5):595-600. PubMed ID: 24965788
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of vigabatrin in Japanese patients with infantile spasms: Primary short-term study and extension study.
Ohtsuka Y
Epilepsy Behav; 2018 Jan; 78():134-141. PubMed ID: 29190579
[TBL] [Abstract][Full Text] [Related]
16. Infantile Spasms-Have We Made Progress?
Kelley SA; Knupp KG
Curr Neurol Neurosci Rep; 2018 Apr; 18(5):27. PubMed ID: 29671077
[TBL] [Abstract][Full Text] [Related]
17. A risk-benefit assessment of treatments for infantile spasms.
Nabbout R
Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
[TBL] [Abstract][Full Text] [Related]
18. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
Mackay MT; Weiss SK; Adams-Webber T; Ashwal S; Stephens D; Ballaban-Gill K; Baram TZ; Duchowny M; Hirtz D; Pellock JM; Shields WD; Shinnar S; Wyllie E; Snead OC; ;
Neurology; 2004 May; 62(10):1668-81. PubMed ID: 15159460
[TBL] [Abstract][Full Text] [Related]
19. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
Ibrahim S; Gulab S; Ishaque S; Saleem T
BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
[TBL] [Abstract][Full Text] [Related]
20. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study.
O'Callaghan FJ; Lux AL; Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; Verity CM; Osborne JP
Epilepsia; 2011 Jul; 52(7):1359-64. PubMed ID: 21668442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
